Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico
Clemente Díaz(University of Puerto Rico System), Alexander C. Schmidt(GlaxoSmithKline (United States)), Maribel Campos(University of Puerto Rico System), Stephen J. Thomas(Global Viral), Luis Javier Martínez-González(Walter Reed Army Institute of Research), Jean‐François Toussaint(Université Paris Cité), Kenneth H. Eckels(Walter Reed Army Institute of Research), Edith Lepine(GlaxoSmithKline (United States)), Bruce L. Innis(Universidad de Los Andes, Chile), Richard G. Jarman(Walter Reed Army Institute of Research), Irma Febo(University of Puerto Rico System), Leyi Lin(Walter Reed Army Institute of Research), Rafael De La Barrera(Walter Reed Army Institute of Research)
Cited by 44
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697